Tag Archives: Jens Holstein

BioNTech Q2 2023 update: Advances Oncology Pipeline and Prepares for Omicron-Adapted COVID-19 Vaccine Launch

(IN BRIEF) BioNTech reported its second-quarter 2023 financial results and corporate update, highlighting significant pipeline advancements in oncology with the initiation of BNT316/ONC-392 Phase 3 pivotal trial and positive data updates across multiple technology platforms. The company also prepares for … Read the full press release